Hébert: It's time to stop pharma-driven 'free lunch' approach

Share this article:
The Canadian Medical Association Journal ran an editorial excoriating industry-funded education, which editor-in-chief Dr. Paul Hébert said “embellishes the positive elements of studies and downplays the adverse effects.” “It is time to stop the pharma-driven ‘free-lunch' approach” Hébert concluded.
Share this article:

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.